8-K
filed February 27, 2026, 6:59 PM ET
ticker INDP
CIK 0001857044
other material
confidence high
sentiment negative
materiality 1.00
Indaptus stockholders approve proposals enabling David Lazar to obtain 96.4% control; board changes
Indaptus Therapeutics, Inc.
- Lazar purchased $6.0M of preferred stock; upon conversion, 111M common shares issuable, representing ~96.4% of fully diluted outstanding.
- Authorized common stock increased from 200M to 1B shares; reverse stock split authorized at ratio 1:2 to 1:199.
- Jerome Jabbour and Matthew McMurdo elected as directors; Mark Gilbert and Michael Newman resigned immediately after meeting.
- Stockholders approved stockholder action by written consent and issuance of common stock upon conversion of preferred stock.
- Lazar's nominees now constitute majority of nine-member board; company plans to pursue strategic transaction with target company.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-008326
- form_type
- 8-K
- ticker
- INDP
- cik
- 0001857044
- company_name
- Indaptus Therapeutics, Inc.
- filed_at
- 2026-02-27T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.573416+00:00
- generated_at
- 2026-05-15T23:11:33.993095+00:00
- sec_items
- ["3.03", "5.07", "5.03", "5.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 1.0
- calibrated_materiality_score
- 1.0
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-008326
- json_url
- https://secwatch.observer/filing/0001493152-26-008326.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-008326.md
- text_url
- https://secwatch.observer/filing/0001493152-26-008326.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1857044/000149315226008326/0001493152-26-008326-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1857044/000149315226008326/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
2618b546c3db3411591b70e73c959599191bd1b3
Indaptus Therapeutics, Inc.: Approved amendments to the Charter to increase authorized common stock to 1,000,000,000 shares and permit stockholder action by written consent (effective 2026-02-27).
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
39425ec7e3e69681dc0838e0405fe42b789366c6
Indaptus Therapeutics, Inc.: Amended Section 2.13 of the Bylaws to provide that stockholder action must be at a meeting and not by written consent, unless the Certificate of Incorporation provides otherwise (effective 2026-02-27).
upon filing of the Certificate of Amendment with the Secretary of State of Delaware, Section 2.13 of the Company’s Amended and Restated Bylaws shall be deemed to be amended as follows: “Unless otherwise provided in the Certificate of Incorporation, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders.”
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
b248296a519cdaa1c8e425f3ea74156585186ba1
Indaptus Therapeutics, Inc. underwent a change of control involving David E. Lazar (closed 2026-02-26).
greement (the “Purchase Agreement”) with David E. Lazar (“Mr. Lazar”) pursuant to which he purchased from the Company 300,000 shares of Series AA Convertible Preferred Stock (the “Series AA Preferred Stock”) and 700,000 shares of Series
SEC 8-K Item 2.01/5.01
confidence 0.9
SEC evidence
Comparable filings
SUJA
Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026
SUJA LIFE, INC.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 3.03, 5.03, 5.02, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
same event type: other_material
similar materiality
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
On May 7, 2026, the Company filed an amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware
Filing page
SEC filing
CUK
Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary
CARNIVAL PLC
May 7, 2026, 7:59 PM ET
other_material
Items 1.02, 2.01, 3.01, 3.02, 3.03, 5.01, 5.03, 7.01, 9.01
same fact type: governance_change, ma_transaction
same SEC item: 3.03, 5.01, 5.03, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to "Carnival Corporation Ltd." (the "Redomiciliation" and, together with the DLC Unification, the "DLC Unification and Redomiciliation Transactions").
Filing page
SEC filing
AAWH
Ascend Wellness Holdings completes Class B conversion and annual meeting
Ascend Wellness Holdings, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 5.07, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
On May 5, 2026, the Company filed a Certificate of Retirement with the Secretary of State of the State of Delaware (the “Certificate of Retirement”) to effect the retirement of the 65,000 shares of Class B Common Stock that were issued but no longer outstanding following the Conversion. Pursuant to Section 243(b) of the DGCL, upon its effectiveness, the Certificate of Retirement had the effect of amending the Certificate of Incorporation to reduce the total number of authorized shares of common stock of the Company by 65,000, to 750,035,000, and to reduce the number of authorized shares of Class B Common Stock by 65,000, to 35,000.
Filing page
SEC filing
IOT
Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026
Samsara Inc.
June 1, 2026, 4:07 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.
Filing page
SEC filing
GIG
GigCapital7 domestication from Cayman Islands to Delaware effective May 8 after shareholder vote
GigCapital7 Corp.
May 11, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
On May 8, 2026, GigCapital7 effectuated the Domestication by filing (i) a voluntary declaration pursuant to Section 206(3) of the Companies Act (revised) of the Acts of the Cayman Islands, (ii) a certificate of corporate domestication with the Secretary of State of the State of Delaware (the “ DE SoS ”), and (iii) an interim certificate of incorporation with the DE SoS (the “ Domesticated GigCapital7 Charter ”). Domesticated GigCapital7 also adopted bylaws (the “ Domesticated GigCapital7 Bylaws ” and together with the Domesticated GigCapital7 Charter, the “ Domesticated GigCapital7 Governing Documents ”) in connection with the Domestication.
Filing page
SEC filing
MRNA
Moderna amends bylaws for federal forum exclusivity; stockholders re-elect directors
Moderna, Inc.
May 11, 2026, 7:59 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
On May 6, 2026 , the Board of Directors (the “Board”) of Moderna, Inc. (the “Company”) approved an amendment to the Company’s Second Amended and Restated By-Laws (the “By-Law Amendment”), effective immediately, to designate the federal district courts of the United States as the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, unless the Company consents in writing to the selection of an alternative forum.
Filing page
SEC filing
LKQ
LKQ stockholders approve 25% special meeting right; all director nominees elected
LKQ CORP
May 8, 2026, 7:59 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
This filing
stockholders of the Company approved amendments to the Company’s Charter to (i) increase the number of authorized shares of our common stock to 1,000,000,000 (one billion) shares, and (ii) permit stockholder approval by written consent in lieu of a meeting.
Comparable filing
the Company’s stockholders, upon the recommendation of the Company’s board of directors (the “Board”), approved an amendment (the “Charter Amendment”) to the Company’s Restated Certificate of Incorporation to provide stockholders holding a combined 25% or more of the Company’s common stock with the right to request a special meeting of stockholders.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.